Tau and ApoE4's impact on myelin-making brain cells
Investigating tau and ApoE4-mediated alterations in oligodendrocyte progenitor cells
Researchers are looking at how Alzheimer-related tau protein and the APOE ε4 gene change the brain cells that make myelin, which could affect memory and thinking for people at risk of Alzheimer's.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Florida NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-11052499 on NIH RePORTER |
What this research studies
From a patient's perspective, this work examines how tau and the APOE ε4 gene alter oligodendrocyte progenitor cells, the cells that produce and repair myelin in the brain. Scientists will study cell behavior and gene activity in laboratory models and human brain tissue to see how these factors contribute to myelin loss and white matter damage. They will compare conditions with and without APOE ε4 and test whether ApoE4 makes tau-related damage worse. The team aims to identify cellular processes that could be targeted to protect myelin and slow cognitive decline.
Who could benefit from this research
Good fit: People with early Alzheimer's disease, mild cognitive impairment, or who carry the APOE ε4 gene would be the most relevant candidates for related future studies.
Not a fit: People without Alzheimer's pathology or known genetic risk (non-APOE ε4 carriers) are unlikely to see direct benefits from this basic-science work.
Why it matters
Potential benefit: If successful, this could point to new ways to protect myelin and slow memory and thinking decline in people with or at risk for Alzheimer's.
How similar studies have performed: Previous studies have reported myelin changes in Alzheimer's and links between APOE ε4 and white-matter damage, but directly linking tau and ApoE4 effects on oligodendrocyte progenitors is a newer research direction.
Where this research is happening
Tampa, United States
- University of South Florida — Tampa, United States (Active)
Researchers
- Principal investigator: Cook, Casey N — University of South Florida
- Study coordinator: Cook, Casey N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.